Jennison Associates’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-28,667
| Closed | -$4.64M | – | 630 |
|
|
2021
Q4 | $4.64M | Buy |
+28,667
| New | +$4.64M | ﹤0.01% | 474 |
|
|
2020
Q4 | – | Sell |
-6,233
| Closed | -$1.47M | – | 632 |
|
|
2020
Q3 | $1.47M | Buy |
+6,233
| New | +$1.47M | ﹤0.01% | 516 |
|
|
2020
Q2 | – | Sell |
-7,316
| Closed | -$1.34M | – | 625 |
|
|
2020
Q1 | $1.34M | Buy |
7,316
+174
| +2% | +$31.9K | ﹤0.01% | 463 |
|
|
2019
Q4 | $1.19M | Sell |
7,142
-2,029
| -22% | -$339K | ﹤0.01% | 507 |
|
|
2019
Q3 | $1.2M | Sell |
9,171
-136
| -1% | -$17.8K | ﹤0.01% | 524 |
|
|
2019
Q2 | $1.13M | Buy |
9,307
+673
| +8% | +$81.7K | ﹤0.01% | 540 |
|
|
2019
Q1 | $1.06M | Buy |
8,634
+2,226
| +35% | +$274K | ﹤0.01% | 532 |
|
|
2018
Q4 | $750K | Buy |
6,408
+126
| +2% | +$14.7K | ﹤0.01% | 557 |
|
|
2018
Q3 | $785K | Sell |
6,282
-73
| -1% | -$9.12K | ﹤0.01% | 571 |
|
|
2018
Q2 | $543K | Sell |
6,355
-2,539
| -29% | -$217K | ﹤0.01% | 618 |
|
|
2018
Q1 | $537K | Sell |
8,894
-35
| -0.4% | -$2.11K | ﹤0.01% | 605 |
|
|
2017
Q4 | $471K | Buy |
8,929
+10
| +0.1% | +$527 | ﹤0.01% | 626 |
|
|
2017
Q3 | $499K | Buy |
8,919
+29
| +0.3% | +$1.62K | ﹤0.01% | 614 |
|
|
2017
Q2 | $558K | Sell |
8,890
-13,350
| -60% | -$838K | ﹤0.01% | 599 |
|
|
2017
Q1 | $1.14M | Sell |
22,240
-9,985
| -31% | -$510K | ﹤0.01% | 563 |
|
|
2016
Q4 | $1.37M | Sell |
32,225
-3,121
| -9% | -$133K | ﹤0.01% | 567 |
|
|
2016
Q3 | $1.68M | Sell |
35,346
-50
| -0.1% | -$2.37K | ﹤0.01% | 555 |
|
|
2016
Q2 | $1.79M | Buy |
35,396
+23,681
| +202% | +$1.2M | ﹤0.01% | 536 |
|
|
2016
Q1 | $566K | Buy |
+11,715
| New | +$566K | ﹤0.01% | 569 |
|